Parachutes and prophylaxis: They both work!

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 6, 2006, Pages 1226-1227

  White II, Gilbert C ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ARTHROPATHY; BLEEDING; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE COURSE; HEMARTHROSIS; HEMOPHILIA; HEMOPHILIA A; HUMAN; LOW DRUG DOSE; NOTE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL;

DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HUMANS;

EID: 33646780549     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01991.x     Document Type: Note

References (14)

1. Ahlberg Å. Haemophilia in Sweden: VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand 1965; 77: 2-132
2. Nilsson IM, Blomback M, Ahlberg Å. Our experience in Sweden with prophylaxis on haemophilia. Bibl Haematol 1970; 34: 111-24.
3. Van Creveld S. Prophylaxis of joint hemorrhages in hemophilia. Acta Haematol 1969; 41: 206-14.
4. Robinson PM, Tittley P, Smiley RK. Prophylactic therapy in classical hemophilia: A preliminary report. CMAJ 1967; 97: 559-61.
5. Aronstam A, Arblaster PG, Rainsford SG, Turk P, Slattery M, Alderson MR, Hall DE, Kirk PJ. Prophylaxis in haemophilia: A double-blind controlled trial. Br J Haematol 1976; 33: 81-90.
6. Schimpf K, Fischer B, Rothmann P. Hemophilia A prophylaxis with factor VIII concentrate in a home-treatment program: A controlled study. Scand J Haematol 1977; 30: 79-80.
7. Stobart K, Iorio A, Wu JK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev 2005; 18: CD003429.
8. Aledort L, Ljung R, Blanchette V. Are randomized clinical trials the only truth? Not always. J Thromb Haemost 2006; 4: 503-4.
9. Mannucci PM. Need for randomized trials in hemophilia. J Thromb Haemost 2006; 4: 501-2.
10. Manco-Johnson MJ, Abshire TC, Brown D, Buchanan GR, Cohen AR, DiMichele D, Hoots WK, Leissinger CA, McRedmond K, Nugent DJ, Shapiro AD, Thomas GA, Valentino LA, Riske B. Initial results of a randomized, prospective trial of prophylaxis to prevent joint disease in young children with factor VIII (FVIII) deficiency. Blood 2005; 106: 6a (abstract).
11. Gingeri A. A prospective controlled studies on prophylaxis: An Italian approach. Haemophilia 2003; 9: 38-42.
12. Guyette GH, Sackett DL, Sinclair J., Hayward R, Cook DJ, Cook RJ. Users' Guides to the medical literature: IX. A method for grading health care recommendations. JAMA 1995; 274: 1800-4.
13. Feldman BM, Pai M, Rivard GE, Israels S, Poon M-C, Demers C, Robinson S, Luke K-H, Wu JKM, Gill K, Lillicrap D, Babyn P, McLimont M, Blanchette V, on behalf of the Association of Hemophilia Clinic Directors of Canada Prophylaxis Study Group. Tailored prophylaxis in severe hemophilia A: interim results from first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost 2006; 4: 1228-36.
14. Brettler DB, Forsberg AD, O'Connell FD, Cederbaum AI, Chaitman AK, Levine PH. A long-term study of hemophilic arthropathy of the knee joint on a program of factor VIII replacement given at each hemarthrosis. Am J Hematol 1985; 18: 13-8.